Skip to main content
Year archive

RHYTHM BIOSCIENCES LIMITED — 2025 filings

All 93 regulatory filings released by RHYTHM BIOSCIENCES LIMITED (RHY) in 2025, sourced directly from the official regulator.

93 Filings
2025 Period
2025 filings (93)
Filing Released Lang
Notification regarding unquoted securities - RHY 6 pages 18.7KB
Share Issue/Capital Change
2025-12-22 English
Proposed issue of securities - RHY 5 pages 17.3KB
Capital/Financing Update
2025-12-18 English
Proposed issue of securities - RHY 5 pages 17.2KB
Share Issue/Capital Change
2025-12-17 English
Rhythm Initiates Commercialisation of ColoSTAT 2 pages 460.9KB
Capital/Financing Update
2025-12-11 English
National Health Service of England Evaluation of ColoSTAT 2 pages 365.6KB
Regulatory Filings
2025-12-09 English
Departure of Chief Financial Officer 1 page 326.2KB
Board/Management Information
2025-12-09 English
RHY enters a US marketing partnership with Catch Bio 2 pages 432.6KB
Capital/Financing Update
2025-12-08 English
Notification regarding unquoted securities - RHY 8 pages 26.8KB
Share Issue/Capital Change
2025-12-02 English
Cleansing Notice 2 pages 451.2KB
Capital/Financing Update
2025-12-02 English
Notification regarding unquoted securities - RHY 7 pages 21.2KB
Capital/Financing Update
2025-12-02 English
Notification of cessation of securities - RHY 4 pages 14.9KB
Regulatory Filings
2025-12-02 English
Change of Director's Interest Notice - Sue MacLeman 2 pages 146.0KB
Director's Dealing
2025-12-02 English
Change of Director's Interest Notice - Gavin Fox-Smith 2 pages 145.1KB
Director's Dealing
2025-12-02 English
Change of Director's Interest Notice - David Atkins 2 pages 147.2KB
Director's Dealing
2025-12-02 English
NATA ISO15189 Certification Genetype Laboratory Operations 2 pages 484.9KB
Regulatory Filings
2025-12-01 English
RHYOA Options Range of Units and Top 20 Holders 3 pages 139.0KB
Major Shareholding Notification
2025-12-01 English
Application for quotation of securities - RHY 10 pages 30.5KB
Regulatory Filings
2025-12-01 English
Notification regarding unquoted securities - RHY 7 pages 22.5KB
Share Issue/Capital Change
2025-12-01 English
Notification regarding unquoted securities - RHY 6 pages 18.6KB
Share Issue/Capital Change
2025-12-01 English
Clinical Validation of the geneType Ovarian Cancer Model 2 pages 478.0KB
Regulatory Filings
2025-11-30 English
Investor Presentation 4 pages 703.1KB
Investor Presentation
2025-11-25 English
FY2025 R&D Tax Incentive Received & Loan Repayment 2 pages 8.2MB
Capital/Financing Update
2025-11-17 English
Post-AGM Investor Presentation 15 pages 1.4MB
AGM Information
2025-11-04 English
Gavin Fox-Smith appointed Chair of Rhythm Biosciences 2 pages 422.6KB
Board/Management Information
2025-11-04 English
Results of Meeting 3 pages 355.3KB
Declaration of Voting Results & Voting Rights Announcements
2025-11-04 English
Final Director's Interest Notice - Otto Buttula 2 pages 133.4KB
Director's Dealing
2025-11-04 English
ColoSTAT Clinical performance update 2 pages 429.3KB
Regulatory Filings
2025-10-29 English
Appendix 4C and Market Update 11 pages 835.0KB
Interim / Quarterly Report
2025-10-28 English
Investor Presentation 21 pages 2.2MB
Investor Presentation
2025-10-09 English
Notice of Annual General Meeting/Proxy Form 55 pages 1.2MB
AGM Information
2025-10-06 English
RHY FY2025 Annual Report 34 pages 5.6MB
Annual Report
2025-09-28 English
Appendix 4G & Corporate Governance Statement 24 pages 565.0KB
Regulatory Filings
2025-09-28 English
Application for quotation of securities - RHY 6 pages 18.3KB
Share Issue/Capital Change
2025-09-17 English
Cleansing Notice 2 pages 450.8KB
Capital/Financing Update
2025-09-17 English
Proposed issue of securities - RHY 5 pages 17.1KB
Share Issue/Capital Change
2025-09-16 English
AGM date and closing date for director nominations 1
AGM Information
2025-09-08 English
Appendix 4E 2 pages 163.8KB
Earnings Release
2025-08-28 English
RHY Financial Report FY2025 60 pages 1.8MB
Annual Report
2025-08-28 English
Strategic partnership with Know Your Lemons Foundation 2 pages 487.1KB
Regulatory Filings
2025-08-27 English
Application for quotation of securities - RHY 6 pages 18.3KB
Share Issue/Capital Change
2025-08-26 English
Cleansing Notice 2 pages 373.4KB
Capital/Financing Update
2025-08-26 English
Change in substantial holding - Otto Buttula 3 pages 609.8KB
Regulatory Filings
2025-08-26 English
ColoSTAT Kit Validation Completion and NATA Submission 2 pages 475.7KB
Regulatory Filings
2025-08-25 English
Share Placement to Raise Up To $3.75 million 3 pages 8.4MB
Capital/Financing Update
2025-08-17 English
Proposed issue of securities - RHY 8 pages 30.0KB
Capital/Financing Update
2025-08-17 English
Proposed issue of securities - RHY 5 pages 17.8KB
Capital/Financing Update
2025-08-17 English
Placement Issue Investor Presentation 14 pages 1.2MB
Capital/Financing Update
2025-08-17 English
Placement Prospectus 38 pages 454.8KB
Capital/Financing Update
2025-08-17 English
Trading Halt 2 pages 420.6KB
Capital/Financing Update
2025-08-13 English
Change in substantial holding 3 pages 231.0KB
Major Shareholding Notification
2025-08-07 English
Response to ASX Price Query 4 pages 8.3MB
Regulatory Filings
2025-08-05 English
ColoSTAT Kits Deliver Breakthrough Results 2 pages 475.9KB
Capital/Financing Update
2025-08-03 English
Notification regarding unquoted securities - RHY 6 pages 18.5KB
Share Issue/Capital Change
2025-07-31 English
Notification of cessation of securities - RHY 4 pages 15.3KB
Share Issue/Capital Change
2025-07-31 English
Jun 25 Quarterly Activities Report and Appendix 4C 11 pages 1.4MB
Interim / Quarterly Report
2025-07-30 English
Genetype MSK Research Collaboration 2 pages 351.2KB
Capital/Financing Update
2025-07-23 English
Strategic Genetype Pilot with Leading Australian Pathology 2 pages 423.3KB
Capital/Financing Update
2025-07-16 English
Change in substantial holding - Otto Buttula 3 pages 635.6KB
Regulatory Filings
2025-07-08 English
Change of Director's Interest Notice - Otto Buttula 3 pages 540.9KB
Regulatory Filings
2025-07-08 English
Change in substantial holding 3 pages 249.8KB
Major Shareholding Notification
2025-07-02 English
FY2025 R&D Tax Incentive Loan Funding 2 pages 8.2MB
Capital/Financing Update
2025-06-29 English
NATA Accreditation Awarded for Genetype Laboratory 2 pages 476.4KB
Capital/Financing Update
2025-06-23 English
Board Composition Update Succession Plan 3 pages 8.3MB
Board/Management Information
2025-06-22 English
Ceasing to be a substantial holder 2 pages 573.8KB
Regulatory Filings
2025-06-22 English
Overview of Genetype Presentation 30 pages 3.0MB
Investor Presentation
2025-06-18 English
Genetype Publication Market Update 2 pages 419.8KB
Regulatory Filings
2025-06-10 English
Change in substantial holding - Michelle Wing 3 pages 428.0KB
Regulatory Filings
2025-06-09 English
Investor Presentation 17 pages 1.7MB
Investor Presentation
2025-06-01 English
Application for quotation of securities - RHY 6 pages 18.2KB
Share Issue/Capital Change
2025-06-01 English
Cleansing Notice 2 pages 375.2KB
Regulatory Filings
2025-06-01 English
Proposed issue of securities - RHY 5 pages 17.1KB
Capital/Financing Update
2025-05-29 English
ColoSTAT Beta kit verification and validation update 3 pages 8.2MB
Capital/Financing Update
2025-05-25 English
Breast Cancer Risk Study University of Melbourne 2 pages 441.8KB
Capital/Financing Update
2025-05-14 English
Notification regarding unquoted securities - RHY 5 pages 16.8KB
Share Issue/Capital Change
2025-05-01 English
Proposed issue of securities - RHY 5 pages 17.0KB
Capital/Financing Update
2025-04-30 English
Quarterly Activities Report and Appendix 4C 31 March 2025 10 pages 689.2KB
Interim / Quarterly Report
2025-04-23 English
RHY ISO13485 Recert Market Update 2 pages 360.8KB
Regulatory Filings
2025-04-13 English
Application for quotation of securities - RHY 6 pages 18.9KB
Share Issue/Capital Change
2025-04-10 English
Change in substantial holding 3 pages 302.0KB
Major Shareholding Notification
2025-04-07 English
EGM - Investor Presentation 19 pages 1.3MB
Investor Presentation
2025-03-30 English
RHY - Results of Meeting 2 pages 263.4KB
Declaration of Voting Results & Voting Rights Announcements
2025-03-30 English
RHY Genetype Commercial Sales 2 pages 346.9KB
Capital/Financing Update
2025-03-18 English
Appointment of Chief Financial Officer 2 pages 334.6KB
Board/Management Information
2025-03-17 English
Notification regarding unquoted securities - RHY 6 pages 19.0KB
Share Issue/Capital Change
2025-03-17 English
Notification of cessation of securities - RHY 4 pages 14.8KB
Regulatory Filings
2025-03-16 English
RHY Investor Webinar 17 pages 1.2MB
Investor Presentation
2025-03-04 English
Investor Webinar 1 page 248.8KB
Investor Presentation
2025-02-26 English
RHY - EGM Notice of Meeting and Proxy Form 22 pages 981.9KB
Proxy Solicitation & Information Statement
2025-02-26 English
Half-Year Financial Report and Appendix 4D 22 pages 2.8MB
Interim / Quarterly Report
2025-02-20 English
Becoming a substantial holder 3 pages 222.8KB
Major Shareholding Notification
2025-02-11 English
Genetype Commercial Integration Completion 3 pages 353.8KB
Capital/Financing Update
2025-02-03 English
Quarterly Activities Report and Appendix 4C - Dec24 9 pages 2.7MB
Interim / Quarterly Report
2025-01-22 English
About the Genetype Acquisition 11 pages 926.5KB
Investor Presentation
2025-01-13 English